PRTN3 and cancer: This might be related to the recognition of tumor antigens [epitopes like Wilms tumor 1(WT-1), proteinase-3, cancer-testis antigens (CTAs)] by specific anti-tumoral CD8+ T cells that target clonal hematopoietic cells and inhibit disease evolution.